Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN Studies In Patients With Stable Angina Managed as Elective Case : MECHANISM-Elective
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Stent thrombosis
- Focus Therapeutic Use
- Acronyms MECHANISM-Elective
- 29 Aug 2017 Planned End Date changed from 1 Jan 2015 to 31 Dec 2018.
- 29 Aug 2017 Planned primary completion date changed from 1 Jan 2015 to 31 Dec 2017.
- 18 Sep 2015 New Source identified and integratED ( University Hospital Medical Information Network - Japan: UMIN000012616 )